About
Meelie Bordoloi, MD, is a board-certified psychiatrist who provides evidence-based care for children, adolescents and adults with complex psychiatric and neurodevelopmental needs, including autism spectrum disorder (ASD), and the use and effect of drugs in treating psychiatric conditions in young people.
Education & Training
Medical School
Assam Medical College
Residency
Psychiatry
- University of Missouri School of Medicine
- University of Missouri School of Medicine
Fellowship
Child and Adolescent Psychiatry
- University of Missouri School of Medicine
Boards
Insurances
MU Health Care participates with most major managed care organizations. To find out whether MU Health Care is a participating provider in your insurance plan or network, or for information on co-payments and deductibles, please contact your insurance carrier directly.
In the News
Academic Information
Research Profile
Meelie Bordoloi, MD, is an adult, child and adolescent psychiatrist and associate professor who focuses on advancing evidence-based care for individuals with complex psychiatric and neurodevelopmental disorders, with particular emphasis on autism spectrum disorder (ASD), pediatric psychopharmacology, patient safety and innovative biologic treatments in psychiatry. Through peer-reviewed publications, she has contributed to research examining psychiatric comorbidities, treatment approaches and challenges related to the diagnosis and treatment of ASD and related neurodevelopmental disorders.
Dr. Bordoloi’s research work and expertise was recognized in her sole authorship of the chapter on ASD in Conn’s Current Therapy 2025 (Elsevier), a widely used clinical reference for practicing physicians. Her scholarly work has also included research in interventional psychiatry and psychopharmacology, contributing to publications exploring transcranial magnetic stimulation (TMS) and other neuromodulation-based treatments for refractory psychiatric disorders. In parallel, Dr. Bordoloi has led quality improvement and patient safety research within the child psychiatry inpatient unit, examining patterns of restrictive interventions, safety events and systems-level opportunities to improve care delivery for high-acuity pediatric populations.
Collectively, Dr. Bordoloi’s scholarship reflects a commitment to translational, clinically meaningful research aimed at improving psychiatric care delivery, advancing therapeutic innovation and strengthening outcomes for vulnerable children and adolescents with complex mental health needs.
Research Interests
- Autism spectrum disorder
- Interventional Psychiatry
- TMS/Esketamine
- Catatonia
- Early onset psychosis
- Patient safety and quality improvement
Research Areas of Expertise
- CAP inpatient systems of care
- Medical education
- Autism spectrum disorder/Neurodevelopment
- TMS
- Program leadership
Awards & Honors
- Physician Leadership Development Academy graduate 2025
- ROCAP (Regional AACAP) Secretary 2025 to present
- AADPRT General member 2022 to present
- AACAP General member 2017 to Present
Publications
- Bordoloi M, Wheeler, H, Rigby J.
Beyond the Threshold: Demographic and Operational Drivers of Restrictive Events in a Child Psychiatry Unit.
Journal of the American Academy of Child & Adolescent Psychiatry, Volume 64, Issue 10, S258 - S259 - Mori-Kreiner A, Aggarwal A, Bordoloi M.
Hallucinogen-Persisting Perception Disorder in a 16-Year-Old Adolescent. Psychopharmacol Bull. 2025 Feb 3;55(2):94-99. PMID: 39935673; PMCID: PMC11809505 - Sadhu, M., & Bordoloi, M.
Laser Light Therapy in the Treatment of ASD: A Systematic Review.
Journal of the American Academy of Child and Adolescent Psychiatry. Volume 63, Issue 10, S268-S269 - Bordoloi M, Durkin I, Aggarwal A.
Effects of Pornography on Youth: A Review.
Mo Med. 2024 May-Jun;121(3):195-197. PMID: 38854615; PMCID: PMC11160374 - Muaid Ithman, Geetha Chandrashekar, Meelie Bordoloi.
Use of Transcranial magnetic stimulation in Treatment-Resistant Depression in MU health care: Effectiveness and outcome 2022:25 (4) - Ithman M, Marshall L, Chandrashekar G, Bordoloi M, Brandt K.
Catatonia Associated with Clonazepam Withdrawal.
Psychiatric Annals. 2020;50(11):513-516. doi:10.3928/00485713-20201006-03 - Meelie Bordoloi, Geetha Chandrashekar, Matthew Schmidt, Muaid Ithman.
Use of Transcranial Magnetic Stimulation in treatment-resistant depression in MU health care: Effectiveness and outcome.
Brain Stimulation: Basic, translational, and Clinical Research in neuromodulation. 2020. 13(6) 1852. - Bordoloi, M., Chandrashekar, G. & Yarasi, N.
ADHD in adult and relation to Methamphetamine use:
National data Curr Dev Disord Rep (2019) 6: 224. - Bordoloi M, Ramtekkar U.
Relationship between Sleep and Psychosis in the Pediatric Population: A Brief Review.
Medical Sciences. 2018; 6(3):76. - Ithman, M., Malhotra, K., Bordoloi, M., & Singh, G. (2018).
Treatment-Refractory Mania with Psychosis in a Post-Transplant Patient on Tacrolimus: A Case Report.
Clinical Medicine & Research. Retrieved from - Bordoloi, M., Singh, G., & Ithman, M.
(2018). 157 Treatment-Refractory Mania with Psychosis in Post-Transplant Patient on Tacrolimus: A Case Report.
CNS Spectrums, 23(1), 96-97. doi:10.1017/S1092852918000494 - Bordoloi M and Devi R,
“Study of serum zinc and copper levels in viral hepatitis in indigenous Assamese population of urban Kamrup district of Assam”
Journal of Datta Meghe Institute of Medical Sciences University 5(2010):74-77 ( Prior to 2011, Journal was not archived
Book Chapter
- Bordoloi, M
(2025)
Autism spectrum Disorder. R. Kellerman (Ed), Conn’s Current Therapy 2025 (869-873). Elsevier